Clinical Trials Sponsored by Carlos Pena, PhD, MS
Total 1 results
-
Carlos Pena, PhD, MSTerminatedEpilepsy | Primary Dystonia | Hydrocephalus | Bladder Control | Hearing Impaired (Partially)
Sponsors and Collaborators
- Rui-hua Xu, MD, PhD
- Celtaxsys Aus Pty Limited
- Elim Pediatric Pharmaceuticals Inc.
- Caritas Freetown
- Fondren Orthopedic Group L.L.P.
- Societa Italiana di Endoscopia Digestiva
- San MediTech(Huzhou)Co.,Ltd.
- Norsk Proteinintolerance, Norway
- Alberta Children's Hospital, Calgary, Canada
- ProteoSys AG
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- The Fifth Affiliated Hospital of Zunyi Medical College
- Donders Institute for Brain, Cognition and Behavior
- University Medical Center Goettingen
- Diego Hernan Giunta, MD
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- Victor Montori
- AMTC & Associates
- CRMBM-CEMEREM
- Cardresearch
- View Full List
Medical Conditions
- Malignant Ascites Due to Epithelial Carcinoma
- Postcomatose Unawareness State
- Atrial Fibrillation, Postoperative
- Non-compressible Torso Hemorrhage
- Fever, Sweats, and Hot Flashes
- Disturbance of Activity and Attention
- Lymphedema of Arm
- Orbital Tumor
- Non-dystrophic Myotonias
- Tube Disorders Eustachian
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Auditory Hallucination, Verbal
- Stereotactic Radioablation for Ventricular Tachycardia
- Spermatogenesis Arrest
- Prostate Cancer Recurrent
- Plasmodium Falciparum Malaria (Drug Resistant)
- Gynecologic Cancer
- Fibromyalgia Syndrome, Primary
- Tularaemia
- Normal Diameter of Optic Nerve
- View Full List
Drug Interventions
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Bortezomib/dexamethasone
- Mupirocin Calcium
- Lamivudine
- Atezolizumab
- Insulin
- Epimedium Prenylflavonoids Extract
- Indoximod
- SERETIDE Diskus
- Oxycodone, fentanyl
- Flibanserin 100 mg dose every evening
- PF-00868554
- Enzalutamide, Abiraterone
- Polyethylene glycol 3350
- Methotrexate
- Cetrorelix 78 mg + 78 mg
- Topotecan
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Ruxolitinib
- Cytarabine ARA-C
- View Full List
CROs by country
- Contract Research Organizations in Brazil
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Gambia
- Contract Research Organizations in Italy
- Contract Research Organizations in Malawi
- Contract Research Organizations in Malta
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Poland
- Contract Research Organizations in Portugal
- Contract Research Organizations in Slovakia
- Contract Research Organizations in Vietnam
- CRO list by country